Is Post-Transplant Cyclophosphamide the New Methotrexate?

Introducing post-transplant, cyclophosphamide (PT-Cy) graft-versus-host disease (GVHD) prophylaxis in the setting of haploidentical donor transplantation has marked the most important advance in allogeneic hematopoietic cell transplantation (alloHCT) within the past 15 years. The efficacy of this pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussetti, Alberto, Paviglianiti, Annalisa, Parody, Rocio, Sureda, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397193/
https://www.ncbi.nlm.nih.gov/pubmed/34441843
http://dx.doi.org/10.3390/jcm10163548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397193/
https://www.ncbi.nlm.nih.gov/pubmed/34441843
http://dx.doi.org/10.3390/jcm10163548

Ejemplares similares